Our Approach
We recognize that companies in the innovation economy have unique financing requirements during their growth cycle. Our specialized team leverages their industry knowledge and extensive deal experience to offer tailored growth and working capital solutions to further accelerate the strategic plans of high growth tech and life science companies across North America, United Kingdom and select European countries.
Our focus is industry agnostic
Technology
- Enterprise & B2B software
- SMB software
- Infrastructure software
- Disruptive technology
- Clean technology
Life sciences
- Medical devices
- Life science tools
- Diagnostics
- Biotech/Pharma
- Healthcare IT
- Healthcare services
We lend at every stage of growth
Startup stage
- Hyper revenue growth
- Strong gross margins
- EBITDA negative
Focused on:
- Product development
- Demonstrating market fit
- Initial customer acquisition
- Implementing a sales strategy
Growth stage
- Continued revenue momentum
- Strong gross margins
- EBITDA negative or positive
Focused on:
- Scaling the business
- Increased sales and marketing
- Growing the employee base
- Ongoing investment in research and development
- Emphasis on new customers acquisitions
Late stage
- Sustainable revenue growth
- EBITDA positive
- Established customer relationships
- Recognizable products and services
Focused on:
- Deepening market penetration
- Entering new markets
- Evaluation of organic and inorganic growth strategies
- Ongoing product development and evaluation of new verticals
We pursue excellence
Fund Banking
CIBC Innovation Banking supports all sizes of venture capital and growth equity firms.
As an investor, we understand your priority is deal origination and enhancing your internal rate of return. Your fund and firm's finances require security, predictability and flexibility.
Our team offers capital call lines, subscription lines, management working capital lines and partner loans in addition to CIBC’s cash management capabilities.
